Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Theratechnologies Inc
(NQ:
THTX
)
1.300
+0.050 (+4.00%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Oct 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Theratechnologies Inc
< Previous
1
2
3
4
5
6
Next >
Theratechnologies Earnings Preview
February 20, 2024
Via
Benzinga
Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action
February 20, 2024
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
February 15, 2024
From
Theratechnologies
Via
GlobeNewswire
Earnings Outlook For Theratechnologies
September 25, 2023
Via
Benzinga
Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
February 06, 2024
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA
January 24, 2024
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application
January 23, 2024
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA
January 02, 2024
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose
December 13, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award
November 24, 2023
Honor awarded last night recognizes Theratechnologies and Prof. Borhane Annabi for advancing preclinical development of sudocetaxel zendusortide for treatment of triple-negative breast cancer
From
Theratechnologies
Via
GlobeNewswire
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
Theratechnologies Announces Closing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
October 31, 2023
From
Theratechnologies
Via
GlobeNewswire
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 26, 2023
Gainers
Via
Benzinga
PLTR Stock Alert: Study Ranks Palantir as Top AI Vendor
October 26, 2023
Palantir Technologies stock is in the news as PLTR investors react of the company being named the top AI vendor for 2023.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
CHPT Stock: ChargePoint Unveils New Software Solutions for Fleet Management
October 26, 2023
ChargePoint stock is on the move Thursday as investors in CHPT react to the release of a new suite of tools for fleet owners.
Via
InvestorPlace
Why Is Theratechnologies (THTX) Stock Down 22% Today?
October 26, 2023
Theratechnologies stock is falling hard on Thursday after the company priced a public offering and private placement for THTX shares.
Via
InvestorPlace
Why Endeavor Group Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
October 26, 2023
Gainers Appreciate Holdings, Inc. (NASDAQ: SFR) shares surged 103.8% to $0.2460 in pre-market trading after falling around 19% on Wednesday. Appreciate Holdings received a notice from Nasdaq regarding...
Via
Benzinga
Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement
October 26, 2023
From
Theratechnologies
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
October 26, 2023
It's time to start off Thursday with a breakdown of the biggest pre-market stock movers investors will want to watch this morning.
Via
InvestorPlace
Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement
October 25, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Operational Update
October 24, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies’ Ibalizumab Demonstrates Cost-Effectiveness as an Addition to Routine Clinical Care in Heavily Treatment-Experienced People with HIV
October 19, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon
October 16, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs)
October 13, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study
October 13, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
October 12, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin F8 Formulation sBLA
October 04, 2023
From
Theratechnologies
Via
GlobeNewswire
Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
September 26, 2023
From
Theratechnologies
Via
GlobeNewswire
Earnings Scheduled For September 26, 2023
September 26, 2023
Companies Reporting Before The Bell • Ferguson (NYSE:FERG) is estimated to report quarterly earnings at $2.46 per share on revenue of $7.60 billion.
Via
Benzinga
Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility
September 25, 2023
From
Theratechnologies
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.